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DBCO-PEG 4 -AH 2 -TG97 Synthesis
Synthesis of Benzyl 2-((tert-butoxycarbonyl)amino)-5-hydroxypentanoate, [A]:
Synthesis of A was performed according to previously published methods. 1 Boc-Glu(OBn) (1 g, 1 equiv) and N-Methylmorpholine (3.55 mmol, 1.2 equiv) were dissolved in 3 mL glyme and stirred at -15°C. Iso-Butyloxychloride (2.96 mmol, 1 equiv) was then added and the mixture was stirred for an additional 15 min. The resulting white precipitate was filtered off and NaBH 4 (4.44 mmol, 1.5 equiv) was added to the filtrate, along with 4 mL of water, and stirred for 15 min. The reaction mixture was dissolved in Ethyl Acetate (EtOAc) and extracted with brine three times.
The organic layer was dried over Mg 2 SO 4 and rotavapped at 40°C. Pure product was obtained on drying (0.726 g, 76%). Chemical characterization via 1 H NMR and mass spectroscopy confirmed formation of the product. ((24R)-19,24-bis((benzyloxy)carbonyl)-3,10,17,22-tetraoxo-1-phenyl-2-oxa-4,11,18,23- Figure S1 . The structure of DBCO-PEG 4 -AH 2 -TG97. Chemical Formula: C 59 H 86 N 7 O 22 P.
Synthesis
Synthesis of dibenzyl 2-(((R)-(benzyloxy)(
Predicted Molecular Weight: 1276.32 g/mol. DBCO-Dibenzylcyclooctyne, PEGpolyethyleneglycol, AH-aminohexanoic acid, TG97-inhibitor of PMSA. S10 Figure S2 . TG97 toxicity and cell killing analysis. LNCaP cells were incubated with TG97 (0 or 2.7 µM) for 2.5 hrs. Excess TG97 was removed via washing, and 5-FC was added to the
